Sample | Title | Value | Rank |
GSM52504 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1) | 1104.9 | 96 |
GSM52508 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2) | 1189.6 | 96 |
GSM52518 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1) | 970.3 | 95 |
GSM52519 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2) | 976.4 | 95 |
GSM52516 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1) | 907.6 | 95 |
GSM52517 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2) | 1005 | 95 |